Published :
Tables : 46
Figures : 43
Category : Healthcare
No. of Pages : 216
Report Code : HC-U2960
Nerve Repair and Re-generation Market is forecasted to value over CAGR of 14% from the forecast period 2022-2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Nerve Repair and Re-generation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market. According to the research study conducted by FutureWise research analysts, the Nerve Repair and Re-generation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the Nerve Repair and Re-generation Market along with the growth opportunities present across this business vertical. Major players included in the Nerve Repair and Re-generation Market are: Stryker Axogen Integra Polyganics Baxter Boston Scientific Livanova Medtronic Abbott Laboratories Nuvectra Neuropace Orthomed Nevro (Note: The list of the major players will be updated with the latest market scenario and trends) Nerve Repair and Re-generation Market Segmentation: By Product • Neurostimulation and Neuromodulation Devices o Internal Neurostimulation Devices o Spinal Cord Stimulation o Deep Brain Stimulation o Vagus Nerve Stimulation o Sacral Nerve Stimulation o Gastric Electrical Stimulation o External Neurostimulation Devices o Transcutaneous Electrical Nerve Stimulation o Transcranial Magnetic Stimulation • Biomaterials o Nerve Conduits o Nerve Protectors o Nerve Wraps o Nerve Connectors By Application • Neurostimulation and Neuromodulation Surgeries o Internal Neurostimulation and Neuromodulation Surgeries o External Neurostimulation and Neuromodulation Surgeries • Direct Nerve Repair/Neurorrhaphy o Epineural Repair o Perineural Repair o Group Fascicular Repair • Nerve Grafting o Autografts o Allografts o Xenografts • Stem Cell Therapy By End User • Hospitals & Clinics • Ambulatory Surgery Centers By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Nerve Repair and Re-generation Market by product, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record and evaluate competitive landscape mapping- product launches, technological advan Terumoents, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Nerve Repair and Re-generation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of the market. According to the research study conducted by FutureWise research analysts, the Nerve Repair and Re-generation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the Nerve Repair and Re-generation Market along with the growth opportunities present across this business vertical. Major players included in the Nerve Repair and Re-generation Market are:
(Note: The list of the major players will be updated with the latest market scenario and trends)
Nerve Repair and Re-generation Market Segmentation:
By Product
• Neurostimulation and Neuromodulation Devices o Internal Neurostimulation Devices o Spinal Cord Stimulation o Deep Brain Stimulation o Vagus Nerve Stimulation o Sacral Nerve Stimulation o Gastric Electrical Stimulation o External Neurostimulation Devices o Transcutaneous Electrical Nerve Stimulation o Transcranial Magnetic Stimulation • Biomaterials o Nerve Conduits o Nerve Protectors o Nerve Wraps o Nerve Connectors
By Application
• Neurostimulation and Neuromodulation Surgeries o Internal Neurostimulation and Neuromodulation Surgeries o External Neurostimulation and Neuromodulation Surgeries • Direct Nerve Repair/Neurorrhaphy o Epineural Repair o Perineural Repair o Group Fascicular Repair • Nerve Grafting o Autografts o Allografts o Xenografts • Stem Cell Therapy
By End User
• Hospitals & Clinics • Ambulatory Surgery Centers
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Nerve Repair and Re-generation Market by product, by application, by end-user and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record and evaluate competitive landscape mapping- product launches, technological advan Terumoents, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization services offered are free of charge with purchase of any license of the report. • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Nerve Repair and Re-generation Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Nerve Repair and Re-generation Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Nerve Repair and Re-generation Market, By product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Neurostimulation and Neuromodulation Devices 7.1.1. Internal Neurostimulation Devices 7.1.1.1. Spinal Cord Stimulation 7.1.1.2. Deep Brain Stimulation 7.1.1.3. Vagus Nerve Stimulation 7.1.1.4. Sacral Nerve Stimulation 7.1.1.5. Gastric Electrical Stimulation 7.1.2. External Neurostimulation Devices 7.1.2.1. Transcutaneous Electrical Nerve Stimulation 7.1.2.2. Transcranial Magnetic Stimulation 7.2. Biomaterials 7.2.1. Nerve Conduits 7.2.2. Nerve Protectors 7.2.3. Nerve Wraps 7.2.4. Nerve Connectors 8. Global Nerve Repair and Re-generation Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Neurostimulation and Neuromodulation Surgeries 8.1.1. Internal Neurostimulation and Neuromodulation Surgeries 8.1.2. External Neurostimulation and Neuromodulation Surgeries 8.2. Direct Nerve Repair/Neurorrhaphy 8.2.1. Epineural Repair 8.2.2. Perineural Repair 8.2.3. Group Fascicular Repair 8.3. Nerve Grafting 8.3.1. Autografts 8.3.2. Allografts 8.3.3. Xenografts 8.4. Stem Cell Therapy 9. Global Nerve Repair and Re-generation Market, By end-user Historical Analysis and Forecast 2022-2028 (USD Million) 9.1.Hospitals & Clinics 9.2.Ambulatory Surgery Centers 10. North America Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) along with expected regulatory needs 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Europe Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Switzerland 11.2.9. Rest of Western Europe 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) - along with expected regulatory needs 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Japan 12.2.2. China 12.2.3. Singapore 12.2.4. India 12.2.5. Australia and New Zealand 12.2.6. ASEAN 12.2.7. South Korea 12.2.8. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA 13.3. Market Size (USD Million) Forecast for MEA 2022-2028 14. Rest of the World Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) along with expected regulatory needs 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 15.1. Stryker 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. AXOGEN 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. INTEGRA 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. Polyganics 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5. Baxter 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6. Boston Scientific 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Livanova 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Medtronic 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Abbott Laboratories 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. Nuvectra 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11. Neuropace 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Orthomed 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Nevro 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations 17. FutureWise SME key takeaway points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Nerve Repair and Re-generation Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Nerve Repair and Re-generation Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Nerve Repair and Re-generation Market, By product Historical Analysis and Forecast 2022-2028 (USD Million)
7.1. Neurostimulation and Neuromodulation Devices
7.1.1. Internal Neurostimulation Devices
7.1.1.1. Spinal Cord Stimulation
7.1.1.2. Deep Brain Stimulation
7.1.1.3. Vagus Nerve Stimulation
7.1.1.4. Sacral Nerve Stimulation
7.1.1.5. Gastric Electrical Stimulation
7.1.2. External Neurostimulation Devices
7.1.2.1. Transcutaneous Electrical Nerve Stimulation
7.1.2.2. Transcranial Magnetic Stimulation
7.2. Biomaterials
7.2.1. Nerve Conduits
7.2.2. Nerve Protectors
7.2.3. Nerve Wraps
7.2.4. Nerve Connectors
8. Global Nerve Repair and Re-generation Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
8.1. Neurostimulation and Neuromodulation Surgeries
8.1.1. Internal Neurostimulation and Neuromodulation Surgeries
8.1.2. External Neurostimulation and Neuromodulation Surgeries
8.2. Direct Nerve Repair/Neurorrhaphy
8.2.1. Epineural Repair
8.2.2. Perineural Repair
8.2.3. Group Fascicular Repair
8.3. Nerve Grafting
8.3.1. Autografts
8.3.2. Allografts
8.3.3. Xenografts
8.4. Stem Cell Therapy
9. Global Nerve Repair and Re-generation Market, By end-user Historical Analysis and Forecast 2022-2028 (USD Million)
9.1.Hospitals & Clinics
9.2.Ambulatory Surgery Centers
10. North America Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) along with expected regulatory needs 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2022-2028 11. Europe Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Switzerland 11.2.9. Rest of Western Europe 12. Asia Pacific Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) - along with expected regulatory needs 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Japan 12.2.2. China 12.2.3. Singapore 12.2.4. India 12.2.5. Australia and New Zealand 12.2.6. ASEAN 12.2.7. South Korea 12.2.8. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
13. Middle East and Africa Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. GCC 13.2.2. Israel 13.2.3. South Africa 13.2.4. Rest of MEA
13.3. Market Size (USD Million) Forecast for MEA 2022-2028
14. Rest of the World Market Analysis 2015–2019 and Forecast 2022–2028 (USD Million) along with expected regulatory needs 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2022-2028 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
15.1. Stryker
15.1.1. Company Overview
15.1.2. Product Portfolio
15.1.3. SWOT Analysis
15.1.4. Financial Overview
15.1.5. Strategic Overview
15.2. AXOGEN
15.2.1. Company Overview
15.2.2. Product Portfolio
15.2.3. SWOT Analysis
15.2.4. Financial Overview
15.2.5. Strategic Overview
15.3. INTEGRA
15.3.1. Company Overview
15.3.2. Product Portfolio
15.3.3. SWOT Analysis
15.3.4. Financial Overview
15.3.5. Strategic Overview
15.4. Polyganics
15.4.1. Company Overview
15.4.2. Product Portfolio
15.4.3. SWOT Analysis
15.4.4. Financial Overview
15.4.5. Strategic Overview
15.5. Baxter
15.5.1. Company Overview
15.5.2. Product Portfolio
15.5.3. SWOT Analysis
15.5.4. Financial Overview
15.5.5. Strategic Overview
15.6. Boston Scientific
15.6.1. Company Overview
15.6.2. Product Portfolio
15.6.3. SWOT Analysis
15.6.4. Financial Overview
15.6.5. Strategic Overview
15.7. Livanova
15.7.1. Company Overview
15.7.2. Product Portfolio
15.7.3. SWOT Analysis
15.7.4. Financial Overview
15.7.5. Strategic Overview
15.8. Medtronic
15.8.1. Company Overview
15.8.2. Product Portfolio
15.8.3. SWOT Analysis
15.8.4. Financial Overview
15.8.5. Strategic Overview
15.9. Abbott Laboratories
15.9.1. Company Overview
15.9.2. Product Portfolio
15.9.3. SWOT Analysis
15.9.4. Financial Overview
15.9.5. Strategic Overview
15.10. Nuvectra
15.10.1. Company Overview
15.10.2. Product Portfolio
15.10.3. SWOT Analysis
15.10.4. Financial Overview
15.10.5. Strategic Overview
15.11. Neuropace
15.11.1. Company Overview
15.11.2. Product Portfolio
15.11.3. SWOT Analysis
15.11.4. Financial Overview
15.11.5. Strategic Overview
15.12. Orthomed
15.12.1. Company Overview
15.12.2. Product Portfolio
15.12.3. SWOT Analysis
15.12.4. Financial Overview
15.12.5. Strategic Overview
15.13. Nevro
15.13.1. Company Overview
15.13.2. Product Portfolio
15.13.3. SWOT Analysis
15.13.4. Financial Overview
15.13.5. Strategic Overview 16. Pre and Post COVID-19 Impact 16.1. Positive influence on the healthcare industry 16.2. The financial disruption of the manufacturing sector 16.3. Impact of COVID-19 on emerging companies 16.4. Significant mandates in the healthcare regulations initiated by administrations 16.5. The overall economic slowdown of the developing and developed nations
17. FutureWise SME key takeaway points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics